Clinical Trials Arena on MSN7d
INOVIO’s Covid-19 dMAb maintains in-vivo detection in 100% participants
Results saw all 24 healthy volunteers who made it to the 72-week mark still had effective levels of dMAB in their systems.
BioPharma Dive11d
SynWeave™: Revolutionizing biopharma manufacturing by improving titer, timelines and manufacturability
Biopharma companies require optimal clone yields to ensure maximum concentration and effectiveness of these therapeutic ...
Medscape1mon
Monoclonal Antibodies in Rheumatoid Arthritis
No writing assistance was utilized in the production of this manuscript. Monoclonal antibodies are novel therapeutic agents used with great success in the treatment of rheumatoid arthritis (RA).
MyChesCo on MSN5d
INOVIO Reports Groundbreaking Results in COVID-19 Antibody Trial
INOVIO (NASDAQ: INO) has announced notable interim findings from a Phase 1 clinical trial testing DNA-encoded monoclonal ...
INOVIO Announces Promising Interim Results from Ongoing Proof-of-Concept Clinical Trial of DNA-Encoded Monoclonal Antibodies (DMAbs) for COVID-19
INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, today ...
Nature26d
Strategies and challenges for the next generation of therapeutic antibodies
Following the success of the first generation of monoclonal antibody blockbusters ... have to be made to decrease the costs of industrial production by increasing the productivity of the current ...
Seeking Alpha14d
IPA ImmunoPrecise Antibodies Ltd.
and producing monoclonal antibodies against conformational epitopes. The company also offers syngeneic cell line for immunization and screening; peptide production for subsequent antibody ...
Fierce Biotech11d
J&J opts out of licensing Genmab's Darzalex challenger after look at phase 1/2 data
Johnson & Johnson is dropping a partnership with Genmab centered around a CD38 monoclonal antibody, prompting the latter ...